Business
Coherus BioSciences to Report Second Quarter 2022 Financial Results on August 4th, 2022
REDWOOD CITY, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its second quarter 2022
About this update from Coherus Oncology, Inc.
[{"type":"text","content":"REDWOOD CITY, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its second quarter 2022 financial results will be released after market close on Thursday, August 4th, 2022. Starting at 5 p.m. ET, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update. After releasing second quarter 2022 financial results, the Company will post them on the Coherus website at https://investors.coherus.com. Conference Call InformationWhen: Thursday, August 4th, 2022, starting at 5 p.m. ETDial-in: (800) 715-9871 (Toll-Free U.S. and Canada) or (646) 307-1963 (International)Conference ID: 8699439 Webcast: https://investors.coherus.com/upcoming-events Please dial-in 15 minutes early to ensure a timely connection to the call. Coherus Contact Information:Marek Ciszewski, J.D.SVP, Investor RelationsCoherus BioSciences, [email protected] \nSource: Coherus BioSciences, Inc.","length":3146,"tagName":"div"}]